Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Rheumatoid Arthritis

  Free Subscription


12.07.2021

3 Ann Rheum Dis
4 Arthritis Res Ther
1 Clin Exp Rheumatol
2 Clin Rheumatol
1 Eur J Radiol
2 PLoS One
2 Rheumatol Int
3 Z Rheumatol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Rheum Dis


  1. Retraction: Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis.
    Ann Rheum Dis. 2021 Jul 6. pii: annrheumdis-2017-211351.
    PubMed        

  2. DUMOULIN QA, Matthijssen XME, Wouters F, Krijbolder DI, et al
    Correspondence on 'Role of joint damage, malalignment and inflammation in articular tenderness in rheumatoid arthritis, psoriatic arthritis and osteoarthritis'.
    Ann Rheum Dis. 2021 Jul 5. pii: annrheumdis-2021-220511.
    PubMed        

  3. GESSL I, Aletaha D, Mandl P
    Response to: 'Correspondence on 'Role of joint damage, malalignment and inflammation in articular tenderness in rheumatoid arthritis, psoriatic arthritis and osteoarthritis'' by Dumoulin et al.
    Ann Rheum Dis. 2021 Jul 5. pii: annrheumdis-2021-220922.
    PubMed        


    Arthritis Res Ther

  4. JUNG SY, Koh JH, Kim KJ, Park YW, et al
    Switching from TNFalpha inhibitor to tacrolimus as maintenance therapy in rheumatoid arthritis after achieving low disease activity with TNFalpha inhibitors and methotrexate: 24-week result from a non-randomized, prospective, active-controlled trial.
    Arthritis Res Ther. 2021;23:182.
    PubMed         Abstract available

  5. CORRADO A, Rotondo C, Mele A, Cici D, et al
    Influence of glucocorticoid treatment on trabecular bone score and bone remodeling regulators in early rheumatoid arthritis.
    Arthritis Res Ther. 2021;23:180.
    PubMed         Abstract available

  6. KOO BS, Eun S, Shin K, Yoon H, et al
    Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics.
    Arthritis Res Ther. 2021;23:178.
    PubMed         Abstract available

  7. MESSELINK MA, Roodenrijs NMT, van Es B, Hulsbergen-Veelken CAR, et al
    Identification and prediction of difficult-to-treat rheumatoid arthritis patients in structured and unstructured routine care data: results from a hackathon.
    Arthritis Res Ther. 2021;23:184.
    PubMed         Abstract available


    Clin Exp Rheumatol

  8. SILVAGNI E, Sakellariou G, Bortoluzzi A, Giollo A, et al
    One year in review 2021: novelties in the treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2021;39:705-720.
    PubMed         Abstract available


    Clin Rheumatol

  9. ZHANG R, Zhou X, Jin Y, Chang C, et al
    Identification of differential key biomarkers in the synovial tissue between rheumatoid arthritis and osteoarthritis using bioinformatics analysis.
    Clin Rheumatol. 2021 Jul 5. pii: 10.1007/s10067-021-05825.
    PubMed         Abstract available

  10. MACARRON PEREZ P, Morales Lozano MDR, Vadillo Font C, Abasolo Alcazar L, et al
    Multidisciplinary approach in the treatment of tendinous foot involvement in rheumatoid arthritis.
    Clin Rheumatol. 2021 Jul 6. pii: 10.1007/s10067-021-05848.
    PubMed         Abstract available


    Eur J Radiol

  11. MORI Y, Mori N, Izumiyama T, Inoue A, et al
    Mathematical model for histogram analysis of dynamic contrast-enhanced MRI: A method to evaluate the drug treatment response in rheumatoid arthritis.
    Eur J Radiol. 2021;141:109831.
    PubMed         Abstract available


    PLoS One

  12. DEYAB G, Reine TM, Vuong TT, Jenssen T, et al
    Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.
    PLoS One. 2021;16:e0253247.
    PubMed         Abstract available

  13. TAKESHITA A, Nishida K, Yoshida A, Nasu Y, et al
    RANKL expression in chondrocytes and its promotion by lymphotoxin-alpha in the course of cartilage destruction during rheumatoid arthritis.
    PLoS One. 2021;16:e0254268.
    PubMed         Abstract available


    Rheumatol Int

  14. YAGIZ B, Coskun BN, Pehlivan Y, Dalkilic E, et al
    In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?
    Rheumatol Int. 2021 Jul 5. pii: 10.1007/s00296-021-04939.
    PubMed         Abstract available

  15. NAKAJIMA T, Watanabe R, Hashimoto M, Murata K, et al
    Neutrophil count reduction 1 month after initiating tocilizumab can predict clinical remission within 1 year in rheumatoid arthritis patients.
    Rheumatol Int. 2021 Jul 9. pii: 10.1007/s00296-021-04944.
    PubMed         Abstract available


    Z Rheumatol

  16. HO LEE Y, Gyu Song G
    Comparative efficacy and safety of tumor necrosis factor inhibitors and their biosimilars in patients with rheumatoid arthritis having an insufficient response to methotrexate : A network meta-analysis.
    Z Rheumatol. 2021 Jul 5. pii: 10.1007/s00393-021-01041.
    PubMed         Abstract available

  17. LEE YH, Song GG
    Comparative efficacy and safety of infliximab and its biosimilars in patients with rheumatoid arthritis presenting an insufficient response to methotrexate : A network meta-analysis.
    Z Rheumatol. 2021 Jul 6. pii: 10.1007/s00393-021-01040.
    PubMed         Abstract available

  18. SUNG YK, Lee YH
    Placebo and nocebo responses in randomized controlled trials of non-tumor necrosis factor biologics and Janus kinase inhibitors in patients with active rheumatoid arthritis showing insufficient response to tumor necrosis factor inhibitors: A meta-anal
    Z Rheumatol. 2021 Jul 9. pii: 10.1007/s00393-021-01047.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: